Considerations for the clinical use of stem cells in genitourinary regenerative medicine

doi:10.4252/wjsc.v13.i10.1480

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6688)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

299

WORD

122

HTML

3612

Figures (1-3)

383

Tables (1-4)

392

Sum=4808

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

307

Download

757

Sum=1064

Publishing Process of This Article

Item

Count

Browse

311

Download

505

Sum=816

Oct 26, 2021 (publication date) through Jan 19, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Oct 26, 2021; 13(10): 1480-1512
Published online Oct 26, 2021. doi: 10.4252/wjsc.v13.i10.1480

Table 1 In vivo studies for regenerative medicine of urologic tissues (excluding studies using adipose tissue-derived stem cells) (words used in the PubMed research engine (National Library of Medicine): “Urology” “regeneration” “reconstruction” “stem cells”)

Stem cell type	Organ treated	Pathology	Animal model	Ref.
AFSC	Bladder	OAB	Rat	[203,204]
AFSC	Bladder	DUA	Rat	[205]
AFSC	Bladder	PD	Rat	[206]
AFSC	Bladder	Stroke	Rat	[203]
BM-MSC	Bladder	OAB	Rat	[207,208]
BM-MSC	Bladder	pBOO	Rat	[209]
BM-MSC	Bladder	IC/BPS	Rat	[210]
BM-MSC	Bladder	PD	Rat	[206,211]
BM-MSC	Bladder	SCI	Rat	[212-214]
BM-MSC	Bladder	Partial cystectomy	Rat	[215]
BM-MSC	Kidney	Renal regeneration	Mouse	[216]
BM-MSC	Kidney	CKD	Rat	[69,70]
BM-MSC	Kidney	AKI	Rat	[7,71]
BM-MSC	Kidney	AKI	Human	[83]
BM-MSC	Bladder	Partial cystectomy	Rat	[90]
BM-MSC	Urinary sphincter	SUI	Rat	[91]
BM-MSC	Bladder	Hemicystectomy	Dog	[97]
BM-MSC	Bladder	Augmentation	Rat	[98]
BM-MSC	Penis	ED	Rat	[217,218]
BM-MSC	Urethra	Urethroplasty	Rabbit	[103]
DP-SC	Bladder	IC/BPS	Rat	[219]
ESC	Kidney	Reconstruction	Rat/mouse	[88]
ESC-MGE	Bladder	SCI	Mouse	[220]
ESC-MSC	Bladder	IC/BPS	Rat	[221-223]
MDC	Bladder	DUA	Rat	[224,225]
MDC	Bladder	DUA	Mouse	[225]
NPC	Bladder	SCI	Rat	[226-228]
OM-SC	Bladder	SCI	Rat	[229]
Sk-MSC	Bladder	DUA	Rat	[230]
Sk-MSC	Urinary sphincter	SUI	Monkey	[231]
Sk-MSC	Urinary sphincter	SUI	Human	[92-94]
Sk-MSC	Urethra	Urethral defect	Rat	[102]
UCB-MSC	Bladder	OAB	Rat	[232]
UCB-MSC	Bladder	IC/BPS	Rat	[233-235]
UCB-MSC	Bladder	Cerebral Ischemia	Rat	[232]
USC	Bladder	IC/BPS	Rat	[236]
USC	Urethra	Urethral defect	Rabbit	[237]
USC	Penile Cavernous body	ED	Rat	[238]
USC	Kidney	AKI	Rat	[84]
USC	Bladder	Augmentation	Rat	[101]

AKI: Acute kidney injury; ASCs: Adipose-derived stromal/stem cells; BM-MSC: Bone marrow-mesenchymal stem cells; UCB-MSC: Umbilical cord blood-mesenchymal stem cells; USC: Urine derived stem cells; DPSC: Dental pulp stem cells; OAB: Overactive bladder; DUA: Detrusor underactivity; PD: Peyronie’s disease; pBOO: Partial bladder outlet obstruction; IC/PBS: Interstitial cystitis/bladder pain syndrome; SCI: Spinal cord injury; SUI: Stress urinary incontinence.

Citation: Caneparo C, Sorroza-Martinez L, Chabaud S, Fradette J, Bolduc S. Considerations for the clinical use of stem cells in genitourinary regenerative medicine. World J Stem Cells 2021; 13(10): 1480-1512
URL: https://www.wjgnet.com/1948-0210/full/v13/i10/1480.htm
DOI: https://dx.doi.org/10.4252/wjsc.v13.i10.1480